Tytuł pozycji:
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
-
Tytuł:
-
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
-
Autorzy:
-
Pennington, Becky
Alshreef, Abualbishr
Flight, Laura
Metry, Andrew
Poku, Edith
Hykin, Philip
Sivaprasad, Sobha
Prevost, A. Toby
Vasconcelos, Joana C.
Murphy, Caroline
Kelly, Joanna
Yang, Yit
Lotery, Andrew
Williams, Michael
Brazier, John
-
Źródło:
-
PharmacoEconomics. 39(9):1099-1099
-